Cargando…
Clinically relevant cell culture models and their significance in isolation, pathogenesis, vaccine development, repurposing and screening of new drugs for SARS-CoV-2: a systematic review
BACKGROUND: In-Vitro/Cellular evidence is the backbone and vital proof of concept during the development of novel therapeutics as well as drugs repurposing against COVID-19. Choosing an ideal in-vitro model is vital as the virus entry is through ACE2, CD147, and TMPRSS2 dependant and very specific....
Autores principales: | Kumar, Subodh, Sarma, Phulen, Kaur, Hardeep, Prajapat, Manisha, Bhattacharyya, Anusuya, Avti, Pramod, Sehkhar, Nishant, Kaur, Harpinder, Bansal, Seema, Mahendiratta, Saniya, Mahalmani, Vidya M., Singh, Harvinder, Prakash, Ajay, Kuhad, Anurag, Medhi, Bikash |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7836970/ https://www.ncbi.nlm.nih.gov/pubmed/33550034 http://dx.doi.org/10.1016/j.tice.2021.101497 |
Ejemplares similares
-
In silico docking and comparative ADMET profile of different glycogen synthase kinase 3 beta inhibitors as the potential leads for the development of anti-Alzheimer drug therapy
por: Prajapat, Manisha, et al.
Publicado: (2020) -
Structural-Based Virtual Screening of FDA-Approved Drugs Repository for NSP16 Inhibitors, Essential for SARS-COV-2 Invasion Into Host Cells: Elucidation From MM/PBSA Calculation
por: Kumar, Subodh, et al.
Publicado: (2023) -
Structural and conformational analysis of SARS CoV 2 N-CTD revealing monomeric and dimeric active sites during the RNA-binding and stabilization: Insights towards potential inhibitors for N-CTD
por: Chauhan, Arushi, et al.
Publicado: (2021) -
Therapeutic options for the treatment of 2019-novel coronavirus: An evidence-based approach
por: Sarma, Phulen, et al.
Publicado: (2020) -
Virtual screening and molecular dynamics study of approved drugs as inhibitors of spike protein S1 domain and ACE2 interaction in SARS-CoV-2
por: Prajapat, Manisha, et al.
Publicado: (2020)